Table 2.
Correlation between caspase-3 expression and various clinicopathological features of patients with gastric cancer
| Caspase-3 expression | P value | ||
|---|---|---|---|
|
|
|||
| low | high | ||
| n | 42 | 55 | |
| Age | |||
| ≤ 50 | 7 | 17 | |
| > 50 | 35 | 38 | 0.107 |
| Sex | |||
| Male | 33 | 41 | |
| Female | 9 | 14 | 0.644 |
| Tumor site | |||
| Corpus gastricum | 18 | 24 | |
| Fundus gastricus | 18 | 24 | |
| Sinus ventriculi | 6 | 7 | 0.975 |
| Lymph node metastasis | |||
| Negative | 22 | 11 | |
| Positive | 20 | 44 | 0.001 |
| Stage | |||
| I+II | 30 | 26 | |
| III+IV | 12 | 29 | 0.017 |
| Therapy | |||
| Surgery | 22 | 25 | |
| Surgery+others | 20 | 30 | 0.499 |
| Serosal invation | |||
| Negative | 32 | 28 | |
| Positive | 10 | 27 | 0.011 |
| Differentiation | |||
| Poor | 18 | 38 | |
| Otherwise* | 24 | 17 | 0.010 |
*
Otherwise means well-differentiated carcinoma and moderately-differentiated carcinoma.